U.S. Army and National Guard Purchase $500,000 of Cardiac Science Powerheart(R) AEDs

AEDs to Be Deployed at Four Military Facilities Including Nation's Largest Active Duty Armored Post in Fort Hood, Texas 


IRVINE, Calif., Aug. 8  /PRNewswire-FirstCall/ -- Cardiac Science Inc. (NASDAQ:DFIB), a leading manufacturer of life-saving automatic external defibrillators (AEDs) and provider of comprehensive AED/CPR training and AED program management services, announced today that it has received orders for 317 Powerheart(R) G3 AEDs to be delivered in this quarter along with AED/CPR training and program management services valued at more than $500,000 from four major military installations in the U.S.

The military branches awarding contracts to Cardiac Science include the Birmingham, Alabama-based U.S. Army 81st Regional Support Command, the U.S. Army Corps of Engineers, Louisville District; the Maine National Guard and Fort Hood, Texas, the largest active duty armored post in the country.  Fort Hood supports two full armored divisions and covers a total of 339 square miles.

Along with providing AEDs to the U.S. Army 81st Regional Support Command, Cardiac Science will also train more than 2,600 of its personnel at numerous locations in Alabama, Florida, Georgia, Mississippi, Kentucky, North Carolina, South Carolina, and Tennessee.  The Army unit provides command and control and direct support services for more than 30,000 soldiers.

"Our Powerheart AEDs and program services continue to be the leading choice of the U.S. military, which has become a rapidly expanding market for AEDs and AED training," said Raymond W. Cohen, Cardiac Science Chairman and CEO.  "Clearly these military units have the ability to select any AED manufacturer to supply products, but consistently choose Cardiac Science and the Powerheart AED because of our robust self-testing technology, overall product reliability and our ability to provide turnkey AED/CPR training and AED program management services.  We plan to continue to build on these established relationships with the U.S. military with a view toward capturing an increasingly larger share of this important market segment."

About Cardiac Science

Cardiac Science develops, manufactures and markets a complete line of Powerheart(R) brand, automatic public access defibrillators (AEDs), and offers comprehensive AED/CPR training and AED program management services that facilitate successful deployments.  Cardiac Science also manufactures its AED products on a private label basis for other leading medical companies such as Nihon Kohden (Japan), Quinton Cardiology Systems and GE Healthcare.  For more information please visit http://www.cardiacscience.com/ or call 1.949.797.3800.

This press release includes forward-looking statements.  These statements may be identified by the use of forward-looking terminology such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "potential," "predict," "should," or "will," or the negative thereof or other variations thereon or comparable terminology. Cardiac Science has based these forward-looking statements on the current expectations, assumptions, estimates and projections.  While Cardiac Science believes the military deployments to be a benefit to the military personnel and will save lives, these expectations, assumptions, estimates and projections, while reasonable, are forward-looking statements and are only predictions and involve known and unknown risks and uncertainties, many of which are beyond our control.  Certain factors, including those discussed in Cardiac Sciences' Annual Report on Form 10-K for the year ended December 31, 2004, under the heading "Risk Factors," may cause the actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements.  Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements.  We do not undertake any obligation to update any such statements or to publicly announce the results of any revisions to any such statements to reflect future events or developments.

   Contact:  Matt Clawson (Investors)       Michael D. Gioffredi
             Len Hall (Media)               Chief Marketing Officer
             Allen & Caron Inc              Cardiac Science, Inc.
             [phone]                 [phone]
                         
             

DATASOURCE: Cardiac Science Inc.



CONTACT:  Investors, Matt Clawson, , or Media, Len

Hall, , both of Allen & Caron Inc, [phone], for

Cardiac Science Inc.; or Michael D. Gioffredi, Chief Marketing Officer of

Cardiac Science, Inc., [phone], 



Web site:  http://www.cardiacscience.com/ 

Copyright